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Purpose/Objective: In the era of image-guided high-dose 
radiation therapy, accurate and precise definition of the 
target volume is indispensable. Besides computed 
tomography (CT) and magnetic resonance imaging (MRI), 
positron emission tomography (PET) using 18F-
fluorodeoxyglucose (FDG) has found its way into routine 
clinical practice providing functional information, in 
particular for lung cancer [1]. With modern scanners, the 
acquisition of time-resolved, i.e., 4D-images is feasible. 
However, a comparative study of target volumes derived by 
3D- versus 4D-FDG-PET/CT for early and locally advanced 
tumours subjected to internal motion (e.g., respiration in 
lung or liver) is thus far lacking. As a model for these moving 
lesions, we compared manually delineated and (semi-
)automatically segmented 3D/4D-PET/CT-scans in 18 
pulmonary lesions eligible for stereotactic ablative body 
radiotherapy (SABR). 
Materials and Methods: For 11 patients, 12 FDG-PET/CT-
scans with 18 pulmonary lesions were available. Using 
Artiview (Aquilab®) and Rover (ABX®) software, four 
observers independently delineated the gross tumour volume 
(GTV) on the 3D- and 4D-PET/CT scans, respectively, and the 
FDG-PET-scans were (semi-)automatically segmented using 
the Homburger method (HOM), the Rover algorithm (RO), and 
the threshold-based methods 15% and 40% of the SUVmax. By 
summation of the 4D-GTVs an ITV was created, and the ITV-
CT contoured by at least 2 of the observers (ITV-CT-Ref) 
served as golden standard. Volumes and paired Kappa Index 
(KI) were calculated and compared using GraphPad Prism and 
R-software. 
Results: The GTV on 3D-CT was statistically significantly 
smaller than the ITV-CT-Ref (5.3 cc versus 9.8 cc, p=0.0003). 
The automatically segmented 3D-GTV-PET volumes were, 
apart from 3D-GTV-PET-15%, statistically significantly smaller 
than the ITV-CT-Ref (p=0.002). Conversely, the ITV-PET-15% 
was statistically significantly larger than the ITV-CT-Ref 
(p=0.0002), whereas there was no statistically significant 
difference between ITV-CT-Ref and the average ITV-PET-40% 
(7.0 cc), ITV-PET-HOM (8.2 cc), and ITV-PET-RO (7.4 cc). The 
ITV-CT-Ref and ITV-PET-Ref (6.5 cc) did not statistically 
significantly differ (p=0.0542).  
The average KI for the individual observers was 0.78-0.92 for 
the ITV-CTs and 0.68-0.71 for the ITV-PETs. The average KI 
for the (semi-)automatically segmented ITV-PETs were: 0.65 
(ITV-PET-HOM), 0.63 (ITV-PET-RO), 0.55 (ITV-PET-15%), and 
0.67 (ITV-PET-40%). 
These results were irrespective of the primary tumour 
volume, tumour motion and SUVmax. 
Conclusions: For target volume delineation of moving 
lesions, an ITV based on a 3D-FDG-PET-scan is no surrogate 
for an ITV based on 4D-imaging. In addition to the standard 
use of 4D-CT-scans, the value of more advanced (semi-
)automatic segmentation methods for accurate, observer-
independent target volume definition on 4D-PET ought to be 
further elaborated. 
Reference: 
[1] De Ruysscher D, Nestle U, Jeraj R, MacManus M. PET scans 
in radiotherapy planning of lung cancer. Lung Cancer 
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Purpose/Objective: To be relevant for clinical practice, PET-
guided dose painting by numbers (DBPN) treatments should 
deliver dose distributions that are specific to the underlying 
biology. 
In this context, we investigated whether FDG or FAZA DPBN 
leads to dose distributions that differ significantly from a 
simple geometric dose escalation, starting from the contour 
of the GTV drawn on CT. 
Materials and Methods: 8 patients with stage II-III lung 
carcinomas treated by concomitant chemo-radiation were 
included. Patients underwent 4D PET-CT (FDG and FAZA) 
prior to treatment (pre) and at week 2 (w2) and 3 (w3). All 
images were reconstructed in their time-weighted mid-
position (MidP). 
At each time point, MidP FDG and FAZA PET-CT were rigidly 
aligned, while per-treatment images were deformed to pre-
treatment ones. 
Image analysis 
PET SUV values within GTV were pairwise compared on a 
voxel-by-voxel basis at each time point (FDG vs FAZA) and 
between time points (w2/3 vs pre) using Spearman’s 
correlation (rs). 
GTV were divided in 5 equidistant concentric rings, r1 
(border) to r5 (center), and median SUV were compared 
between rings. 
Adaptive planning 
FDG and FAZA voxel-based DPBN treatment plans were 
generated by linearly increasing the dose from median (60Gy) 
to maximum SUV (80Gy) within GTV. Plan conformity was 
assessed by quality volume histogram (QVH) and quality 
factor (QF; target < 5 %). 
Simultaneously, geometrically escalated plans were 
generated by linearly increasing the dose from the border to 
the center of the GTV. 
Dose plans were compared at each time point (FDG/FAZA vs 
geometric) and between time points (w2/3 vs pre) using cross 
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QVH (one’s dose distribution being compared to the other’s 
dose prescription). 
Results 
Image analysis 
At each time point, FDG vs FAZA voxel-by-voxel comparison 
showed high correlation (rs = 0.78 IQR [0.69-0.83]). Similarly, 
uptake distributions were spatially stable between imaging 
sessions for both tracers (FDG: rs = 0.90 [0.85-0.94]; FAZA: rs 
= 0.89 [0.75-0.91]).  
FDG and FAZA median SUV increased linearly from r1 to r5.  
All results were significant (p < 0.01). 
Adaptive planning 
Conformity of FDG and FAZA DPBN plans was achieved (QF = 
1.33 ± 0.19 %). 
At each time point, cross QVH between FDG/FAZA DPBN 
prescriptions and geometric plans showed satisfactory QF 
(FDG: 2.99 ± 0.15 %; FAZA: 3.03 ± 0.21 %) meaning plans 
could be swapped. 
Cross QVH between pre-treatment plans and per-treatment 
prescriptions had acceptable QF as well (FDG: 2.05 ± 0.82 %; 
FAZA: 2.39 ± 0.92 %). 
Conclusions: FDG and FAZA did not clearly show different 
uptake patterns, nor significant temporal changes during RT. 
Notably, the linear increase of SUV towards the center of the 
GTV probably reflects the lack of tracer specificity and the 
typical blur of PET images. As a result, dose distributions 
were highly similar between DPBN and geometric plans. 
Therefore, a CT-based geometric dose escalation might be a 
simpler, as effective, alternative. 
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Purpose/Objective: 10 year follow up after hypo-
fractionated radiation therapy in breast cancer has been 
reported as safe and effective. Maximum lung distance (LD) 
at mid slice (MS), all slices (AS) and maximum heart distance 
(HD) MS or AS has traditionally been used to reduce 
pneumonitis or ischaemic cardiac effects post radiation. 
Improvements in planning with forward planned IMRT (FIMRT) 
often use shielding of heart and lung using mini segments to 
reduce irradiated heart/lungs. This study reports the dose 
volume (DV) correlates for whole breast and chest wall 
planning and analyses if traditional 2d distances (LD MS/AS or 
HD MS/AS) are relevant surrogates for use in the current era. 
Materials and Methods: Plans for 496 consecutive patients' 
who underwent FIMRT to the whole breast or chest wall (and 
/or supraclavicular fossa) to a dose of 4005 cGy in 15 
fractions were analysed. All plans were accepted with target 
coverage between 95-107%. LD MS/AS, HD MS/AS were 
recorded. Mean heart dose(MHD), V2.5, V5 and V30 of heart 
(left sided cancers), mean lung dose (MLD), V5/V10/V20 of 
ipsilateral lung were analyzed from DV histograms (DVH). The 
DVH data was compared for correlation with 2d LD and HD, 
pearsons correlation(r ) calculated and significance analysed. 
Other DVH comparisons, left vs right, whole-breast (WBRT) vs 
chest wall irradiation (CWRT) were compared using the 
Independent samples T test. 
Results: 290 and 206 patients underwent WBRT and CWRT, 
frequency of left vs right were 49.%8, 50.2% respectively. The 
mean of the LD-MS was 2.1 cm (range - 0.5 cm to 3.4 cm) and 
LD-AS was 2.3 cm (range - 0.80 to 3.7 cm).The MLD was 638.8 
cGy (range - 14.6 cGy to 1115.3 cGy). Mean of V5, V10, V20 
of ipsilateral lung were 21.7, 15.6 and 12.8 % respectively. 
Lung V5, V10, V20, MLD, were higher with right sided 
irradiation (p < 0.005). HD MS/AS were 0.6/1.9 cm 
respectively, MHD, V2.5, V5 and V30 in the left sided breast 
cancers were 396.0 cGy (range – 22.8 cGy to 858 cGy), 20.1, 
11.3 and 6.0 % respectively. When comparing WBRT and 
CWRT, the mean LD-MS, LD-AS, V10 and V20 were 
significantly less (p <0.005) with WBRT although there 
weren't any difference in heart DVH. LD-MS correlated 
strongly (P=<0.005) with V5,V10, V20, MLD (r=0.6, 0.7, 0.7, 
0.7) with Linear coefficient (R2)ratio between 0.4-0.5. A 
significant reduction (range 22-46.4%) in V5/10/20 was seen 
with a 5mm 2dLD reduction. HD-AS correlated significantly 
(p<0.005) with V2.5, V5, V30, MHD (r=0.9 for all AND R2 =0.8). 
A 2mm change above 1.7-2.1mm resulted significant DV heart 
changes. 
Conclusions: Significant correlation existed between 2d LD 
and HD with the lung, heart dosimetric parameters 
reiterating their use as surrogate markers to predict lung and 
heart toxicities, even in the era of FIMRT. Significant DVH 
changes can occur with 5mm 2dLD and 2dHD changes, 
highlighting the benefit of segment shielding of heart and 
lungs in breast radiotherapy. 
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Purpose/Objective: Over the past years, treatment for Head 
and Neck Cancer (HNC) has evolved from relatively simple 3D 
conformal therapy to IMRT with static beams and more 
recently to volumetric modulated arc therapy (VMAT) 
techniques using rotational beams. Previous planning studies 
have shown benefits from these modern treatment planning 
systems (TPS) and techniques, but mainly in small and 
selected patient series.  
The purpose of the current study was to quantify the effects 
on dose-volume histogram (DVH) parameters for various 
treatment techniques and 3 different treatment planning 
systems (TPS’s). This was done on a large scale population 
basis using the actual treatment plans delivered in routine 
daily practice. 
Materials and Methods: Between 2006 and 2013, a total of 
270 patients with primary HNC underwent radiation therapy 
